Adaptive Biotechnologies Corporation (FRA:1HM)
Germany · Delayed Price · Currency is EUR 16.82
-0.44 (-2.55%)
Last updated: Dec 1, 2025, 8:02 AM CET
Adaptive Biotechnologies Market Cap
Adaptive Biotechnologies has a market cap or net worth of €2.59 billion as of December 1, 2025. Its market cap has increased by 217.06% in one year.
Market Cap
2.59B
Enterprise Value
2.59B
Revenue
215.42M
Ranking
n/a
PE Ratio
n/a
Stock Price
€16.82
Market Cap Chart
Since June 27, 2019, Adaptive Biotechnologies's market cap has decreased from 4.20B to 2.59B, a decrease of -38.38%. That is a compound annual growth rate of -7.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 1, 2025 | 2.47B | 189.52% |
| Dec 31, 2024 | 854.57M | 33.16% |
| Dec 29, 2023 | 641.78M | -37.23% |
| Dec 30, 2022 | 1.02B | -70.64% |
| Dec 31, 2021 | 3.48B | -47.33% |
| Dec 31, 2020 | 6.61B | 99.43% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 27, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.88B |
| Siemens Aktiengesellschaft | 176.79B |
| Allianz SE | 141.56B |
| Deutsche Telekom AG | 132.19B |
| Siemens Energy AG | 98.23B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.85B |
| Rheinmetall AG | 67.93B |
| Deutsche Bank Aktiengesellschaft | 58.37B |